#NOTICIASDESALUD | Papilocare: el primer gel vaginal de Argentina para tratar el HPV

Health Radio News interviewed Dr. Julieta Brizuela (MN 103.377), a gynecologist, to discuss Papilocare®, the first and only clinically supported vaginal gel option in Argentina for the reversal and management of low-grade HPV-related lesions. "Its arrival in the country is a milestone because it provides Argentine women, for the first time, with a locally applied treatment alternative to actively and effectively manage HPV-related cervical lesions," stated the Director of Education for the Municipality of Malvinas Argentinas and Adjunct Professor at the H.A. Barceló Foundation Faculty of Medicine. Papilocare® represents a significant innovation thanks to its unique non-hormonal formula that utilizes niosome and phytosome technology. This cutting-edge technology guarantees localized and deep action with re-epithelializing properties; mucosal repair and protection; and a prebiotic that rebalances the vaginal microbiota. "Clinical studies demonstrate that Papilocare® achieves normalization of low-grade lesions in a high percentage of patients after only six months of treatment, offering a safe and well-tolerated option for women affected by HPV," the specialist emphasized. Health News® for a better life Subscribe to our YouTube channel ➯    / channel   Official Facebook page of #HealthNews ➯   / noticiasdsalud   Official Instagram page of #HealthNews ➯   / noticiasdesaludradio   Visit us at ➯ www.noticiasdesalud.com.ar X ➯ https://x.com/NotideSalud #HealthNewsRadio #Papilocare #Gynecology #HPV #VaginalHealth